The UK MHRA has approved AstraZeneca's Trixeo Aerosphere inhaler to treat adults with chronic obstructive pulmonary disease ...

The Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

LENZ has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan.

Isolator lines present several significant advantages for large-scale aseptic filling, as Marcel Langner of IDT Biologika ...

Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...

Veraxa Biotech has entered a joint discovery partnership with OmniAb for developing a bispecific antibody drug conjugate ...

AAN conference featured the latest research and developments in neurological disorders like Alzheimer's disease, epilepsy and ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the United States.

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.